Search - tctmd.com

Displaying 661 - 680 of 1310

Sort: Relevancy | Date

News Conference News ESC 2016

Prasugrel, Ticagrelor Give Similar Short-term Outcomes After Primary PCI: PRAGUE-18

Todd Neale

August 30, 2016

News Conference News ESC 2016

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

Shelley Wood

August 29, 2016

News Conference News ESC 2016

Radial Artery Angiograms Save Time, May Reduce Complications in Radial PCI for STEMI

Shelley Wood

August 28, 2016

Presentation ESC 2016

Feasibility and Safety of Direct Catheter - Based Thrombectomy in the Treatment of Acute Ischemic Stroke: Prospective Registry PRAGUE-16

Presenter: Petr Widimsky

August 27, 2016

News Conference News ESC 2016

Thrombectomy for Stroke in a Cardiology Department: Preliminary Study Explores the Possibilities

Todd Neale

August 27, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Industry News

InSeal Medical Ltd. Announces CE Mark Approval for the InClosure Large Bore Vascular Closure Device

August 08, 2016

News Daily News

Weight Loss May Affect Diabetes Risk, but Not Future CVD Outlook

L.A. McKeown

August 04, 2016

News Daily News

更新的 ACTION-GWTG 风险评分旨在更好地预测院内死亡率急性心肌梗死后

Yael L. Maxwell

August 03, 2016

News Daily News

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Yael L. Maxwell

August 03, 2016

News Daily News

La Escala de Riesgo Actualizada de ACTION-GWTG Pretende Predecir Mejor la Mortalidad Intrahospitalaria Post-IAM

Yael L. Maxwell

August 03, 2016

News Daily News

Judge Dismisses AstraZeneca’s Bid to Block Generic Crestor

Shelley Wood

July 20, 2016

News Daily News

AstraZeneca Strives to Block Generic Crestor as Observers Call Foul

Michael O'Riordan

July 13, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

July 11, 2016

News Daily News

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Michael O'Riordan

June 30, 2016

News Daily News

FDA 顾问小组小范围建议使用糖尿病药物 empagliflozin 来改善 CVD 死亡率

Michael O'Riordan

June 30, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

News Daily News

Protein-Based Risk Score Shows Potential for Tailored Medicine in Cardiology

Yael L. Maxwell

June 24, 2016

Presentation

Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable CHD

Presenter: Peter Ganz

June 24, 2016

News Daily News

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

Yael L. Maxwell

June 15, 2016

Advertisement

Prasugrel, Ticagrelor Give Similar Short-term Outcomes After Primary PCI: PRAGUE-18

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

Radial Artery Angiograms Save Time, May Reduce Complications in Radial PCI for STEMI

Feasibility and Safety of Direct Catheter - Based Thrombectomy in the Treatment of Acute Ischemic Stroke: Prospective Registry PRAGUE-16

Thrombectomy for Stroke in a Cardiology Department: Preliminary Study Explores the Possibilities

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

InSeal Medical Ltd. Announces CE Mark Approval for the InClosure Large Bore Vascular Closure Device

Weight Loss May Affect Diabetes Risk, but Not Future CVD Outlook

更新的 ACTION-GWTG 风险评分旨在更好地预测院内死亡率急性心肌梗死后

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

La Escala de Riesgo Actualizada de ACTION-GWTG Pretende Predecir Mejor la Mortalidad Intrahospitalaria Post-IAM

Judge Dismisses AstraZeneca’s Bid to Block Generic Crestor

AstraZeneca Strives to Block Generic Crestor as Observers Call Foul

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

FDA 顾问小组小范围建议使用糖尿病药物 empagliflozin 来改善 CVD 死亡率

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Protein-Based Risk Score Shows Potential for Tailored Medicine in Cardiology

Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable CHD

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content